Francois Nader - Net Worth and Insider Trading

Francois Nader Net Worth

The estimated net worth of Francois Nader is at least $129,110 dollars as of 2024-04-26. Francois Nader is the Director of Talaris Therapeutics Inc and owns about 47,467 shares of Talaris Therapeutics Inc (TALS) stock worth over $129,110. Details can be seen in Francois Nader's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Francois Nader has not made any transactions after 2022-07-21 and currently still holds the listed stock(s).

Transaction Summary of Francois Nader

To

Francois Nader Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Francois Nader owns 7 companies in total, including Prevail Therapeutics Inc (PRVL) , Alexion Pharmaceuticals Inc (ALXN) , and Moderna Inc (MRNA) among others .

Click here to see the complete history of Francois Nader’s form 4 insider trades.

Insider Ownership Summary of Francois Nader

Ticker Comapny Transaction Date Type of Owner
PRVL Prevail Therapeutics Inc 2020-06-17 director
ALXN Alexion Pharmaceuticals Inc 2020-05-14 director
MRNA Moderna Inc 2019-12-10 director
XLRN Acceleron Pharma Inc 2020-01-22 director
BXLT Baxalta Inc 2016-06-03 director
TRVN Trevena Inc 2014-01-30 director
TALS Talaris Therapeutics Inc 2022-07-21 director

Francois Nader Latest Holdings Summary

Francois Nader currently owns a total of 1 stock. Francois Nader owns 47,467 shares of Talaris Therapeutics Inc (TALS) as of July 21, 2022, with a value of $129,110.

Latest Holdings of Francois Nader

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TALS Talaris Therapeutics Inc 2022-07-21 47,467 2.72 129,110

Holding Weightings of Francois Nader


Francois Nader Form 4 Trading Tracker

According to the SEC Form 4 filings, Francois Nader has made a total of 2 transactions in Talaris Therapeutics Inc (TALS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Talaris Therapeutics Inc is the acquisition of 13,850 shares on July 21, 2022, which cost Francois Nader around $499,985.

Insider Trading History of Francois Nader

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Francois Nader Trading Performance

GuruFocus tracks the stock performance after each of Francois Nader's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Francois Nader is -62.23%. GuruFocus also compares Francois Nader's trading performance to market benchmark return within the same time period. The performance of stocks bought by Francois Nader within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Francois Nader's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Francois Nader

Average Return

-18.09%

Average return per transaction

Outperforming Transactions

0%

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.51 -62.23 -65.69 -18.09
Relative Return to S&P 500(%) 2.77 -56.07 -65.03 -31.53

Francois Nader Ownership Network

Ownership Network List of Francois Nader

No Data

Ownership Network Relation of Francois Nader


Francois Nader Owned Company Details

What does Prevail Therapeutics Inc do?

Who are the key executives at Prevail Therapeutics Inc?

Francois Nader is the director of Prevail Therapeutics Inc. Other key executives at Prevail Therapeutics Inc include director & 10 percent owner Carl L Gordon , director & 10 percent owner Peter A. Thompson , and General Counsel Kira M. Schwartz .

Prevail Therapeutics Inc (PRVL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Prevail Therapeutics Inc (PRVL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prevail Therapeutics Inc (PRVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Prevail Therapeutics Inc (PRVL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Prevail Therapeutics Inc Insider Transactions

No Available Data

Francois Nader Mailing Address

Above is the net worth, insider trading, and ownership report for Francois Nader. You might contact Francois Nader via mailing address: 550 Hills Drive, Bedminster Nj 07921.

Discussions on Francois Nader

No discussions yet.